EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+11.77%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$5.8B
AUM Growth
+$5.8B
(-0.69%)
Cap. Flow
-$470M
Cap. Flow
% of AUM
-8.11%
Top 10 Holdings %
Top 10 Hldgs %
24.55%
Holding
197
New
37
Increased
72
Reduced
55
Closed
16
Top Buys
| 1 |
VRNA
Verona Pharma
VRNA
|
$54.6M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$37.8M |
| 3 |
iRhythm Technologies
IRTC
|
$34.5M |
| 4 |
Global E Online
GLBE
|
$22.3M |
| 5 |
Vistra
VST
|
$21.6M |
Top Sells
| 1 |
Trane Technologies
TT
|
$77.8M |
| 2 |
Transmedics
TMDX
|
$71.4M |
| 3 |
Datadog
DDOG
|
$62.8M |
| 4 |
argenx
ARGX
|
$60M |
| 5 |
GitLab
GTLB
|
$48.4M |
Sector Composition
| 1 | Healthcare | 40.6% |
| 2 | Technology | 18.78% |
| 3 | Industrials | 17.39% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Financials | 2.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Revolution Medicines
RVMD
$7.62B
| $23.7M | 0.41% |
523,051
-127,775
| -20% | -$5.79M |
|
77
Southern Company
SO
$100B
| $23.6M | 0.41% |
261,941
-29,472
| -10% | -$2.66M |
|
78
Veracyte
VCYT
$2.4B
| $23.1M | 0.4% |
677,883
+113,883
| +20% | +$3.88M |
|
79
Celcuity
CELC
$2.29B
| $22.9M | 0.39% |
1,535,000
| – | – |
|
80
Verisk Analytics
VRSK
$37.2B
| $22.7M | 0.39% |
84,752
-386
| -0.5% | -$103K |
|
81
Novanta
NOVT
$4.03B
| $22.6M | 0.39% |
126,430
+26
| +0% | +$4.65K |
|
82
International Paper
IP
$26.1B
| $22.3M | 0.39% |
457,235
+117,838
| +35% | +$5.76M |
|
83
Keros Therapeutics
KROS
$651M
| $22.1M | 0.38% |
380,000
-119,208
| -24% | -$6.92M |
|
84
Royalty Pharma
RPRX
$15.8B
| $21.9M | 0.38% |
772,623
+22,993
| +3% | +$650K |
|
|
INZY
85
DELISTED
Inozyme Pharma
INZY
| $21.6M | 0.37% |
4,134,436
+198,216
| +5% | +$1.04M |
|
86
Biohaven
BHVN
$1.78B
| $20M | 0.34% |
399,827
-234,837
| -37% | -$11.7M |
|
87
Equity Residential
EQR
$24.4B
| $19.8M | 0.34% |
+266,088
| New | +$19.8M |
|
|
RCM
88
DELISTED
R1 RCM Inc. Common Stock
RCM
| $19.5M | 0.34% |
1,375,999
+19
| +0% | +$269 |
|
89
Scholar Rock
SRRK
$3.26B
| $19.3M | 0.33% |
2,409,207
-665,268
| -22% | -$5.33M |
|
90
Applied Industrial Technologies
AIT
$9.95B
| $19.2M | 0.33% |
85,923
+5,430
| +7% | +$1.21M |
|
91
Element Solutions
ESI
$6.13B
| $19.1M | 0.33% |
702,168
-99,945
| -12% | -$2.71M |
|
92
Relay Therapeutics
RLAY
$667M
| $19M | 0.33% |
+2,682,083
| New | +$19M |
|
93
BridgeBio Pharma
BBIO
$10B
| $18.3M | 0.31% |
716,927
| – | – |
|
94
Aptiv
APTV
$17.4B
| $18.1M | 0.31% |
251,021
+240
| +0.1% | +$17.3K |
|
95
MSCI
MSCI
$42.6B
| $18.1M | 0.31% |
31,001
-2,274
| -7% | -$1.33M |
|
96
Repligen
RGEN
$6.77B
| $17.7M | 0.31% |
119,000
| – | – |
|
97
Krystal Biotech
KRYS
$4.36B
| $17.4M | 0.3% |
95,781
-40,704
| -30% | -$7.41M |
|
98
Avidity Biosciences
RNA
$6B
| $17.3M | 0.3% |
375,924
| – | – |
|
99
TG Therapeutics
TGTX
$5.06B
| $16.8M | 0.29% |
718,814
| – | – |
|
100
Lexeo Therapeutics
LXEO
$262M
| $16.8M | 0.29% |
1,855,986
-1,513,161
| -45% | -$13.7M |
|